Fund Holdings — Flagship Pioneering Inc.

Total Portfolio Value:
$1.33B
Total Bought:
$6.15M
Total Sold:
$47.57M
Net Transaction:
-$41.42M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Moderna, Inc.(MRNA)9,666,0389,666,0380$998.41M$961.29M72.53%-$37.12M
Sana Biotechnology, Inc.(SANA)25,001,85625,001,8560$96.76M$102.01M7.70%+$5.25M
Omega Therapeutics Inc29,225,57929,225,5790$62.83M$87.97M6.64%+$25.13M
Foghorn Therapeutics Inc.(FHTX)12,674,12012,674,1200$63.37M$81.75M6.17%+$18.38M
Denali Therapeutics Inc.(DNLI)2,619,9682,319,968-300,000$54.05M$49.79M3.76%-$4.26M
Seres Therapeutics, Inc.(MCRB)23,117,04523,117,0450$55.02M$32.43M2.45%-$22.58M
Syros Pharmaceuticals Inc993,8481,293,848+300,000$3.93M$10.08M0.76%+$6.15M
Axcella Health IncCOM1,170,0590-1,170,059$12.22M$0—-$12.22M
Evelo Biosciences IncCOM7,932,6240-7,932,624$31.10M$0—-$31.10M
Page 1 of 1
Flagship Pioneering Inc. — 13F Holdings — Q4 2023 | TickerTrail